Prediction of response to repeat utilization of anthracycline in recurrent breast cancer patients previously administered anthracycline-containing chemotherapeutic regimens as neoadjuvant or adjuvant chemotherapy.

Source:http://linkedlifedata.com/resource/pubmed/id/17063267

Download in:

View as

General Info

PMID
17063267